Lisa A. Kachnic
Columbia University
289 Papers
2K Citations
Lisa A. Kachnic is an academic researcher from Columbia University. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 48, co-authored 251 publications. Previous affiliations of Lisa A. Kachnic include Dresden University of Technology & Emory University.
Chat about Author
Papers
Emerging applications of stereotactic radiotherapy in head and neck cancer.
Minh Tam Truong,Gregory A. Grillone,Christine Tschoe,Lawrence S. Chin,Lisa A. Kachnic,Scharukh Jalisi +5 more
TL;DR: This article focuses on the emerging evidence for the use of stereotactic body radiotherapy for treatment of HNC as a boost after conventional external-beam radiotherapy, and also as reirradiation in recurrent or second primary HNC.
Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital.
Naomi Y. Ko,Julie L Fu,Sarah C Lane,Kathy Finn,Sandy Allten,Nectaria Vassilakis,Lisa Stober,Lisa A. Kachnic,Tracy A. Battaglia +8 more
TL;DR: The findings demonstrate that a formal process of tracking cancerclinical trial screens using an EMR can document baseline rates of institution-specific accrual patterns and identify targeted strategies for increasing cancer clinical trial enrollment among a vulnerable patient population.
Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology.
Lee Steingisser,Brian Acker,Stuart M. Berman,Mark J. Brenner,Bruce A. Bornstein,Paul M. Busse,Thomas J. Fitzgerald,Joseph O. Jacobson,Eliot Jekowsky,Lisa A. Kachnic,Harvey J. Mamon,Andrea B. McKee,Lawrence N. Shulman,Mary Ann Stevenson,David E. Wazer,John A. Fallon +15 more
TL;DR: The normal tissue-based guidelines have decreased the use of IMRT in Massachusetts; increased theUse of 3D treatment; continued communication between treating radiation oncologists and an insurance organization responsible for cost and quality in medicine; increased cost savings; and enabled an efficient appeal process.
9
Homologous recombination research is heating up and ready for therapy
Simon N. Powell,Lisa A. Kachnic +1 more
TL;DR: A report in PNAS suggests that mild hyperthermia can inhibit the process of homologous recombination (HR) and degrade the BRCA2 protein.
9
Daily Orthogonal Kilovoltage Imaging Using a Gantry-Mounted On-Board Imaging System Results in a Reduction in Radiation Therapy Delivery Errors
Gregory A. Russo,Muhammad M. Qureshi,Minh Tam Truong,Ariel E. Hirsch,Lawrence Orlina,Harry K. Bohrs,P. Clancy,John Willins,Lisa A. Kachnic +8 more
TL;DR: IGRT implementation has a patient safety benefit with a significant reduction in treatment delivery errors and is recommended in routine practice to complement existing quality assurance measures.
9